{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:24:15Z","timestamp":1768566255101,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1378\/chest.121.5.1710","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1710-1712","source":"Crossref","is-referenced-by-count":13,"title":["Death Associated With Rifampin and Pyrazinamide 2-Month Treatment of Latent Mycobacterium Tuberculosis"],"prefix":"10.1016","volume":"121","author":[{"given":"Ann","family":"Medinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-6","key":"10.1378\/chest.121.5.1710_bib1","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.121.5.1710_bib2","first-page":"289","article-title":"Fatal and severe hepatitis associated with rifampin, and pyrazinamide for the treatment of latent tuberculosis infection: New York, and Georgia, 2000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.121.5.1710_bib3","first-page":"448","article-title":"Severe hepatotoxicity of tuberculostatic agents: increase in incidence","volume":"19","author":"Moitinho","year":"1996","journal-title":"Gastroenterol Hepatol"},{"key":"10.1378\/chest.121.5.1710_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0025-7125(16)30192-4","article-title":"Preventive therapy for tuberculosis","volume":"77","author":"Miller","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1378\/chest.121.5.1710_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0025-7125(16)30198-5","article-title":"Tuberculosis in the elderly","volume":"77","author":"Dutt","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1378\/chest.121.5.1710_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215348960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215348960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:57:07Z","timestamp":1553115427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215348960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0012369215348960"],"URL":"https:\/\/doi.org\/10.1378\/chest.121.5.1710","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}